|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12P 21/08 | |
| A61P 35/00 | |||
| A61K 39/395 | |||
| C07K 16/28 | |||
| C07K 16/30 |
| (11) | Patento numeris | 2134854 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08726810.8 |
| Europos patento paraiškos padavimo data | 2008-03-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-12-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-04-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/003369 |
| Data | 2008-03-14 |
| (87) | Numeris | WO 2008/115404 |
| Data | 2008-09-25 |
| (30) | Numeris | Data | Šalis |
| 918084 P | 2007-03-15 | US |
| (72) |
CAVENEE, Webster, US
FURNARI, Frank, US
JOHNS, Terrance, Grant, AU
SCOTT, Andrew, AU
|
| (73) |
Ludwig Institute for Cancer Research Ltd.,
605 Third Avenue, New York, NY 10158,
US
|
| (54) | TREATMENT METHOD USING EGFR ANTIBODIES AND SRC INHIBITORS AND RELATED FORMULATIONS |
| TREATMENT METHOD USING EGFR ANTIBODIES AND SRC INHIBITORS AND RELATED FORMULATIONS |